Sunitinib in patients with metastatic renal cell carcinoma of intermediate and high risk groups – Lithuanian National Cancer Institute retrospective analysis
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-11-01
|
Series: | European Urology Open Science |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666168320362339 |
_version_ | 1818379941310365696 |
---|---|
author | V. Urbonas A. Zalimas D. Dabkeviciene A. Ulys A. Matulevicius F. Jankevicius S. Jarmalaite |
author_facet | V. Urbonas A. Zalimas D. Dabkeviciene A. Ulys A. Matulevicius F. Jankevicius S. Jarmalaite |
author_sort | V. Urbonas |
collection | DOAJ |
first_indexed | 2024-12-14T02:10:47Z |
format | Article |
id | doaj.art-f00b2b01b8da4cab84dda8945eb8abca |
institution | Directory Open Access Journal |
issn | 2666-1683 |
language | English |
last_indexed | 2024-12-14T02:10:47Z |
publishDate | 2020-11-01 |
publisher | Elsevier |
record_format | Article |
series | European Urology Open Science |
spelling | doaj.art-f00b2b01b8da4cab84dda8945eb8abca2022-12-21T23:20:46ZengElsevierEuropean Urology Open Science2666-16832020-11-0121S186Sunitinib in patients with metastatic renal cell carcinoma of intermediate and high risk groups – Lithuanian National Cancer Institute retrospective analysisV. UrbonasA. ZalimasD. DabkevicieneA. UlysA. MatuleviciusF. JankeviciusS. Jarmalaitehttp://www.sciencedirect.com/science/article/pii/S2666168320362339 |
spellingShingle | V. Urbonas A. Zalimas D. Dabkeviciene A. Ulys A. Matulevicius F. Jankevicius S. Jarmalaite Sunitinib in patients with metastatic renal cell carcinoma of intermediate and high risk groups – Lithuanian National Cancer Institute retrospective analysis European Urology Open Science |
title | Sunitinib in patients with metastatic renal cell carcinoma of intermediate and high risk groups – Lithuanian National Cancer Institute retrospective analysis |
title_full | Sunitinib in patients with metastatic renal cell carcinoma of intermediate and high risk groups – Lithuanian National Cancer Institute retrospective analysis |
title_fullStr | Sunitinib in patients with metastatic renal cell carcinoma of intermediate and high risk groups – Lithuanian National Cancer Institute retrospective analysis |
title_full_unstemmed | Sunitinib in patients with metastatic renal cell carcinoma of intermediate and high risk groups – Lithuanian National Cancer Institute retrospective analysis |
title_short | Sunitinib in patients with metastatic renal cell carcinoma of intermediate and high risk groups – Lithuanian National Cancer Institute retrospective analysis |
title_sort | sunitinib in patients with metastatic renal cell carcinoma of intermediate and high risk groups lithuanian national cancer institute retrospective analysis |
url | http://www.sciencedirect.com/science/article/pii/S2666168320362339 |
work_keys_str_mv | AT vurbonas sunitinibinpatientswithmetastaticrenalcellcarcinomaofintermediateandhighriskgroupslithuaniannationalcancerinstituteretrospectiveanalysis AT azalimas sunitinibinpatientswithmetastaticrenalcellcarcinomaofintermediateandhighriskgroupslithuaniannationalcancerinstituteretrospectiveanalysis AT ddabkeviciene sunitinibinpatientswithmetastaticrenalcellcarcinomaofintermediateandhighriskgroupslithuaniannationalcancerinstituteretrospectiveanalysis AT aulys sunitinibinpatientswithmetastaticrenalcellcarcinomaofintermediateandhighriskgroupslithuaniannationalcancerinstituteretrospectiveanalysis AT amatulevicius sunitinibinpatientswithmetastaticrenalcellcarcinomaofintermediateandhighriskgroupslithuaniannationalcancerinstituteretrospectiveanalysis AT fjankevicius sunitinibinpatientswithmetastaticrenalcellcarcinomaofintermediateandhighriskgroupslithuaniannationalcancerinstituteretrospectiveanalysis AT sjarmalaite sunitinibinpatientswithmetastaticrenalcellcarcinomaofintermediateandhighriskgroupslithuaniannationalcancerinstituteretrospectiveanalysis |